ondansetron has been researched along with scopolamine hydrobromide in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.50) | 18.7374 |
| 1990's | 10 (25.00) | 18.2507 |
| 2000's | 18 (45.00) | 29.6817 |
| 2010's | 11 (27.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carey, GJ; Costall, B; Domeney, AM; Gerrard, PA; Jones, DN; Naylor, RJ; Tyers, MB | 1 |
| Riekkinen, P; Sirviö, J | 1 |
| Barnes, JM; Costall, B; Coughlan, J; Domeney, AM; Gerrard, PA; Kelly, ME; Naylor, RJ; Onaivi, ES; Tomkins, DM; Tyers, MB | 1 |
| Barnes, GR; Ruddock, CJ; Stott, JR; Wright, RJ | 1 |
| Bratt, AM; Costall, B; Domeney, AM; Kelly, ME; Naylor, RJ | 1 |
| Carli, M; Luschi, R; Samanin, R | 1 |
| Borsini, F; Pitsikas, N | 1 |
| Harder, JA; Kelly, ME | 1 |
| Black, IB; Stäubli, UV; van Praag, H | 1 |
| Greenshaw, AJ; Ivanová, S | 1 |
| Broocks, A; Dubbert, B; Little, JT; Mack, C; Martin, A; Minichiello, MD; Murphy, DL; Sunderland, T; Tune, L | 1 |
| Kaneko, T; Kikusui, T; Tonohiro, T | 1 |
| Clemes, SA; House, F; Palmer, JL; Reid, K; Somal, HS; Stott, JR; Troakes, C; Wright, RJ | 1 |
| Arulmozhi, DK; Babu, RJ; Gupta, CN; Sridhar, N; Veeranjaneyulu, A | 1 |
| Del Río, J; Diez-Ariza, M; García-Alloza, M; Lasheras, B; Ramírez, MJ; Redondo, C | 1 |
| Kela, AK; Kumar, N | 1 |
| Andrews, PL; Cheng, FH; Moreaux, B; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Wan, C | 1 |
| Burkard, JF; Crosby, D; Jones, S; Maye, J; Pellegrini, JE; Strobl, R | 1 |
| Roberge, RJ | 1 |
| Coleman, JE; Kapu, R; Ogunnaike, B; Shah, M; Sloninsky, A; Song, D; Tang, J; Webb, T; Wender, RH; White, PF | 1 |
| Carabuena, JM; Harnett, MJ; O'Rourke, N; Segal, S; Walsh, M | 1 |
| Apiliogullari, S; Duman, A | 1 |
| Guinn, C; Nunley, C; Wakim, J | 1 |
| Battikha, JP; Cohen, SA; Deutsch, JS; Gan, TJ; Glass, PS; Jones, RK; Kovac, AL; Pergolizzi, JV; Sinha, AC | 1 |
| Dalby, P; Kaul, B; Ramesh, V; Sah, N; Shestak, K; Vallejo, MC | 1 |
| Carter, EA; Costantino, M; Jones, MM; Lee, JB; Lee, JS; McCullough, MF; Spies, JB | 1 |
| Li, CH; Shen, YJ; Yin, YQ; Zhang, JH; Zhang, YJ; Zhao, W; Zhu, Q | 1 |
| Mounsey, AL; Russell, RG; Sutton, M | 1 |
| Furyk, JS; McKenzie, S; Meek, R | 1 |
| Banting, J; Meriano, T | 1 |
| Aleshi, P; Chiu, C; Esserman, LJ; Harbell, MW; Inglis-Arkell, C; Whitlock, EL; Yap, E | 1 |
| Cannesson, M; Dhillon, A; Gabel, E; Grogan, T; Hofer, I; Hong, J; Mahajan, A; Moore, J; Shin, J; Ziv, K | 1 |
4 review(s) available for ondansetron and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The effects of stimulation of acupressure point p6 on postoperative nausea and vomiting: a review of literature.
Topics: 2-Propanol; Acupressure; Acupuncture Points; Adult; Antiemetics; Child; Cholinergic Antagonists; Cost of Illness; Cost-Benefit Analysis; Dexamethasone; Humans; Ondansetron; Oxygen Inhalation Therapy; Phytotherapy; Postanesthesia Nursing; Postoperative Nausea and Vomiting; Practice Guidelines as Topic; Research Design; Risk Factors; Scopolamine; Serotonin Antagonists; Treatment Outcome; Zingiber officinale | 2008 |
FPIN's Clinical Inquiries. Treatment of motion sickness.
Topics: Antiemetics; Cholinergic Antagonists; Histamine Antagonists; Humans; Motion Sickness; Ondansetron; Phytotherapy; Scopolamine; Zingiber officinale | 2012 |
Sea State Green.
Topics: Acupressure; Antiemetics; Cholinergic Antagonists; Dopamine Antagonists; Emergency Medical Technicians; Histamine Antagonists; Humans; Meclizine; Metoclopramide; Military Personnel; Motion Sickness; Ondansetron; Promethazine; Scopolamine | 2016 |
10 trial(s) available for ondansetron and scopolamine hydrobromide
| Article | Year |
|---|---|
The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties.
Topics: Adolescent; Adult; Antiemetics; Clinical Trials as Topic; Double-Blind Method; Electrooculography; Eye Movements; Humans; Imidazoles; Male; Middle Aged; Motion Sickness; Ondansetron; Random Allocation; Receptors, Serotonin; Saccades; Scopolamine | 1989 |
The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls.
Topics: Adult; Behavior; Cognition; Female; Humans; Male; Memory; Ondansetron; Parasympatholytics; Piperazines; Psychomotor Performance; Pupil; Reaction Time; Reference Values; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists | 1998 |
Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man.
Topics: Adolescent; Adult; Antiemetics; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Motion Sickness; Nausea; Neurokinin-1 Receptor Antagonists; Ondansetron; Piperidines; Scopolamine; Serotonin Antagonists; Tetrazoles | 2000 |
The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron.
Topics: Administration, Cutaneous; Adult; Antiemetics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Infusions, Intravenous; Male; Muscarinic Antagonists; Nursing Assessment; Ondansetron; Patient Satisfaction; Postoperative Nausea and Vomiting; Prospective Studies; Risk Assessment; Risk Factors; Scopolamine; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms.
Topics: Adjuvants, Anesthesia; Administration, Cutaneous; Adolescent; Adult; Aged; Antiemetics; Bariatric Surgery; Double-Blind Method; Droperidol; Humans; Laparoscopy; Mammaplasty; Middle Aged; Ondansetron; Plastic Surgery Procedures; Postoperative Nausea and Vomiting; Scopolamine | 2007 |
Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery.
Topics: Administration, Cutaneous; Analgesia, Obstetrical; Analgesics, Opioid; Antiemetics; Cesarean Section; Double-Blind Method; Female; Humans; Incidence; Injections, Intravenous; Injections, Spinal; Morphine; Ondansetron; Postoperative Nausea and Vomiting; Pregnancy; Scopolamine; Time Factors; Treatment Outcome | 2007 |
A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
Topics: Administration, Cutaneous; Adult; Ambulatory Surgical Procedures; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Drug Therapy, Combination; Female; Gynecologic Surgical Procedures; Humans; Injections, Intravenous; Laparoscopy; Length of Stay; Mammaplasty; Middle Aged; Ondansetron; Patient Satisfaction; Postoperative Nausea and Vomiting; Scopolamine; Time Factors; Treatment Outcome; United States | 2009 |
Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery.
Topics: Administration, Cutaneous; Adult; Ambulatory Surgical Procedures; Antiemetics; Cholinergic Antagonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ondansetron; Pain; Postoperative Nausea and Vomiting; Prospective Studies; Scopolamine; Surgery, Plastic; Time Factors | 2009 |
Transdermal scopolamine patch with odansetron for the control of nausea after uterine artery embolization compared with odansetron alone: results of a randomized placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Aged; Antiemetics; Delayed-Action Preparations; Drug Combinations; Female; Humans; Middle Aged; Nausea; Ondansetron; Placebo Effect; Scopolamine; Treatment Outcome; Uterine Artery Embolization | 2010 |
[Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section].
Topics: Administration, Intravenous; Adult; Cesarean Section; Female; Humans; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Scopolamine; Treatment Outcome | 2012 |
26 other study(ies) available for ondansetron and scopolamine hydrobromide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset.
Topics: Animals; Arecoline; Callithrix; Cognition; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Imidazoles; Male; Ondansetron; Scopolamine; Serotonin Antagonists | 1992 |
Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate.
Topics: Aging; Alanine; Animals; Antidepressive Agents; Electroencephalography; Electrophysiology; Imidazoles; Male; Methysergide; Ondansetron; Pilocarpine; Rats; Rats, Inbred Strains; Scopolamine; Serotonin Antagonists | 1991 |
The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates.
Topics: Aging; Animals; Arecoline; Brain; Callithrix; Choline O-Acetyltransferase; Cognition; Female; Habituation, Psychophysiologic; Imidazoles; Male; Mice; Ondansetron; Random Allocation; Rats; Scopolamine; Serotonin Antagonists; Single-Blind Method | 1990 |
Ondansetron fails to attenuate a scopolamine-induced deficit in a Stone maze task.
Topics: Animals; Cognition; Dose-Response Relationship, Drug; Male; Maze Learning; Memory; Ondansetron; Rats; Scopolamine; Space Perception | 1994 |
Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist.
Topics: Animals; Cholinergic Antagonists; Discrimination, Psychological; Dose-Response Relationship, Drug; Hippocampus; Injections; Male; Maze Learning; Ondansetron; Parasympathetic Nervous System; Rats; Scopolamine; Serotonin Antagonists; Space Perception; Synaptic Transmission | 1997 |
Different effects of tropisetron and ondansetron in learning and memory paradigms.
Topics: Animals; Avoidance Learning; Indoles; Learning; Male; Maze Learning; Memory; Muscarinic Antagonists; Ondansetron; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Scopolamine; Serotonin Antagonists; Tropisetron | 1997 |
The effect of several putative cognition enhancers on a water maze acquisition deficit produced by pCPA + scopolamine combination treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cholinesterase Inhibitors; Cognition; Drug Interactions; Fenclonine; Male; Maze Learning; Muscarinic Agonists; Muscarinic Antagonists; Ondansetron; Oxotremorine; Rats; Scopolamine; Serotonin Agents; Serotonin Antagonists; Tacrine | 1997 |
Neonatal vs. adult unilateral hippocampal lesions: differential alterations in contralateral hippocampal theta rhythm.
Topics: Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Functional Laterality; Hippocampus; Idazoxan; Male; Muscarinic Antagonists; Ondansetron; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Scopolamine; Serotonin Antagonists; Theta Rhythm | 1997 |
Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron.
Topics: Animals; Conditioning, Operant; Dopamine Antagonists; Haloperidol; Male; Mecamylamine; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Ondansetron; Rats; Rats, Sprague-Dawley; Scopolamine; Self Stimulation; Serotonin Antagonists; Ventral Tegmental Area | 1997 |
The allocentric place discrimination task is selectively and highly dependent on the central muscarinic system in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Diazepam; Discrimination Learning; Dizocilpine Maleate; Flumazenil; Male; Mecamylamine; Ondansetron; Rats; Rats, Inbred F344; Receptors, Muscarinic; Scopolamine; Swimming | 2000 |
5-HT3 receptors in selective animal models of cognition.
Topics: Animals; Biguanides; Cognition; Ligands; Male; Maze Learning; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Scopolamine; Serotonin Antagonists; Signal Transduction | 2002 |
Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.
Topics: Animals; Cholinesterase Inhibitors; Drug Therapy, Combination; Flumazenil; Learning; Male; Maze Learning; Memory; Muscarinic Antagonists; Ondansetron; Rats; Rats, Wistar; Receptors, GABA-A; Scopolamine; Serotonin Antagonists; Tacrine | 2003 |
Ondansetron amelioration of scopolamine induced cognitive deficits in three-panel runway apparatus in rats.
Topics: Animals; Male; Memory; Memory Disorders; Muscarinic Antagonists; Ondansetron; Rats; Rats, Wistar; Scopolamine; Serotonin Antagonists | 2004 |
Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Butanols; Capsaicin; Cyclooxygenase Inhibitors; Dihydroergotamine; Diphenhydramine; Diterpenes; Domperidone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Indomethacin; Malates; Methysergide; Metoclopramide; Migraine Disorders; Ondansetron; Piperidines; Ruthenium Red; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists; Shrews; Sumatriptan; Time Factors; Tropanes; Vomiting | 2005 |
Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch.
Topics: Administration, Topical; Adult; Antiemetics; Dexamethasone; Dopamine Antagonists; Dystonia; Emergency Service, Hospital; Female; Humans; Metoclopramide; Muscarinic Antagonists; Ondansetron; Postoperative Nausea and Vomiting; Prochlorperazine; Scopolamine | 2006 |
Smoking and nalbuphine may reduce postoperative emesis.
Topics: Morphine; Nalbuphine; Ondansetron; Postoperative Nausea and Vomiting; Scopolamine; Smoking | 2008 |
Drug treatment of adults with nausea and vomiting in primary care.
Topics: Adult; Antiemetics; Domperidone; Droperidol; Female; Histamine Antagonists; Humans; Male; Metoclopramide; Morning Sickness; Muscarinic Antagonists; Nausea; Ondansetron; Pregnancy; Primary Health Care; Prochlorperazine; Promethazine; Scopolamine; Vomiting | 2014 |
Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy.
Topics: Acetaminophen; Analgesia; Analgesics; Analgesics, Non-Narcotic; Anesthesia, Conduction; Antiemetics; Dexamethasone; Female; Gabapentin; Humans; Intraoperative Care; Length of Stay; Mastectomy, Simple; Middle Aged; Ondansetron; Pain Management; Postoperative Nausea and Vomiting; Preoperative Care; Retrospective Studies; Scopolamine | 2018 |
Digital Quality Improvement Approach Reduces the Need for Rescue Antiemetics in High-Risk Patients: A Comparative Effectiveness Study Using Interrupted Time Series and Propensity Score Matching Analysis.
Topics: Adolescent; Adult; Aged; Algorithms; Anesthesia, General; Antiemetics; Child; Comparative Effectiveness Research; Data Collection; Decision Support Systems, Clinical; Dexamethasone; Electronic Health Records; Feedback; Female; Humans; Incidence; Interrupted Time Series Analysis; Los Angeles; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Propensity Score; Quality Improvement; Risk; Scopolamine; Young Adult | 2019 |